IRIS
BONATI, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.057
EU - Europa 1.539
AS - Asia 1.162
AF - Africa 29
OC - Oceania 6
SA - Sud America 2
Totale 4.795
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.009
CN - Cina 712
IE - Irlanda 314
SG - Singapore 299
SE - Svezia 274
IT - Italia 253
FI - Finlandia 235
UA - Ucraina 213
DE - Germania 178
TR - Turchia 103
CA - Canada 48
CI - Costa d'Avorio 27
GB - Regno Unito 20
JP - Giappone 18
BE - Belgio 14
IN - India 12
AT - Austria 10
NL - Olanda 10
AU - Australia 5
CZ - Repubblica Ceca 5
HK - Hong Kong 4
IR - Iran 4
KR - Corea 4
ES - Italia 3
TW - Taiwan 3
BG - Bulgaria 2
BR - Brasile 2
PK - Pakistan 2
RO - Romania 2
CH - Svizzera 1
EE - Estonia 1
FR - Francia 1
GE - Georgia 1
HU - Ungheria 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 4.795
Salva come PNG Salva come JPEG
Città #
Chandler 333
Jacksonville 322
Dublin 313
Singapore 247
Beijing 188
Santa Clara 176
Nanjing 113
Ann Arbor 105
Boardman 99
Izmir 91
Parma 88
Dearborn 87
Ashburn 76
Princeton 71
San Mateo 71
Jinan 47
Wilmington 47
Toronto 46
Hebei 41
Shenyang 39
Shanghai 31
Des Moines 30
Nanchang 29
Abidjan 27
Kunming 27
Helsinki 24
Hefei 20
Düsseldorf 18
New York 18
Tokyo 18
Bologna 17
Woodbridge 17
Changsha 15
Tianjin 15
Brussels 14
Los Angeles 14
Guangzhou 13
Falls Church 12
Zhengzhou 12
Fremont 11
Grafing 11
Kocaeli 10
Taizhou 10
Haikou 9
Jiaxing 9
Leawood 9
Vienna 9
Fuzhou 8
Lanzhou 8
Milan 8
Seattle 8
Bremen 7
Hangzhou 7
Redmond 7
Trezzano Sul Naviglio 7
Borås 6
Chengdu 6
Houston 6
Modena 6
Munich 6
Taiyuan 6
Ningbo 5
Redwood City 5
Verona 5
Amsterdam 4
Dallas 4
Langhirano 4
Mestre 4
Novara 4
Savignano Sul Rubicone 4
Auburn Hills 3
Chongqing 3
London 3
Mountain View 3
Piacenza 3
Pune 3
Reggio Nell'emilia 3
San Felice Sul Panaro 3
Suwon 3
Taipei 3
Xian 3
Ardabil 2
Arzano 2
Brno 2
Cambridge 2
Cremona 2
Fairfield 2
Focsani 2
Gurgaon 2
Guwahati 2
Hong Kong 2
Inzago 2
Lumezzane 2
Madrid 2
Marghera 2
Miami 2
Monmouth Junction 2
Mumbai 2
Olomouc 2
Padova 2
Totale 3.255
Salva come PNG Salva come JPEG
Nome #
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma 208
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 134
Lung cancer in patients with chronic lymphocytic leukemia: does the HER-2 oncogene play a role? 89
Treatment with Arsenic Trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 86
Elevated telomerase activity, minimal telomere loss in cord blood long-term cultures with extensive stem cell replication 83
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein. 79
Pan-aurora kinase inhibitor MK-0457 synergistically potentiates Apo2l/TRAIL cytotoxicity in Multiple Mieloma cells sensitive and resistant to bortezomib 76
Early proinflammatory activation of renal tubular cells by normal and pathologic IgG 75
Biochemical, Immunological, and Molecular Markers of Hemopoietic Precursor Cells. 75
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activity. 75
Ph1-positive acute myelocytic leukemia with high TdT levels. 74
MEK1/2 KINASES DISABLE THE TUMOR SUPPRESSOR FUNCTIONS OF NATIVE BCR AND ABL1 KINASES TO IMPAIR ANTICANCER DRUGS’ RESPONSIVENESS IN TKI-RESISTANT PHILADELPHIA POSITIVE LEUKEMIAS 73
Terminal deoxynucleotidyl transferase (TdT) levels in hairy cell leukemia. 73
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis 72
BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. 72
T cell receptor genes: a glance at normal and malignant hematopoiesis. 72
The new tumor suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of pro-angiogenic molecules by myeloma cells and suppresses hypoxia inducible factor (HIF)-1{alpha} activity being involved in myeloma-induced angiogenesis. 72
Su di un caso di sclerodermia associato ad aplasia midollare globale. 71
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent anti-tumor activity in vivo against human multiple myeloma xenograft model. 71
Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL 70
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts. 69
Human T-cell receptor alpha chain gene during ontogeny 69
Arsenic Trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells 69
Arsenic Trioxide in hematological malignancies: the new discovery of an ancient drug. 68
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 67
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 66
Synthesis, spectroscopic characterization and biological properties of new natural aldehydes thiosemicarbazones 66
Emerging MEK inhibitors 66
Espressione degli antigeni CD1a, CD1b, CD1c in timo umano a diverse eta' dello sviluppo. 66
p73 and p53 pathway in human breast cancers. 66
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. 65
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia 65
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors 64
La mielofibrosi idiopatica asplenomegalica. Osservazioni cliniche e considerazioni su cinque casi. 64
Synthesis, characterisation, X-ray structure and biological activity of three new 5-formyluracil thiosemicarbazone complexes 64
Effect of the protein tyrosine kinase inhibitor genistein on normal and leukaemic haemopoietic progenitor cells. 63
Emerging Raf inhibitors 62
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterization. 62
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 62
Discordant expression of terminal transferase and T cell receptor beta chain in fetal and pediatric thymocytes. 62
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4. 62
The fine structure of HNK-1 (Leu7) positive cells. A study using an immunoperoxidase technique. 61
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts 61
Terminal deoxynucleotidyl transferase: a nuclear marker of hemopoietic precursors. Biochemical, immunological and clinical aspects. 61
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia 60
Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers. 59
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligands. 58
La linfoadenopatia angio-immunoblastica: Osservazioni cliniche, patologiche ed immunologiche su di un caso. 58
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 57
Phenotype of the terminal transferase-positive cells in human foetal liver and bone-marrow: analysis with monoclonal antibodies. 56
TCR beta chain expression during human thymic development. 56
Hemopoiesis during human fetal life. Present knowledge and future prospects. 55
Valutazione dell'attivita proliferativa delle cellule emopoietiche nelle sindromi preleucemiche. 55
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 55
Terminal deoxynucleotidyl transferase in human fetal tissues. 54
Targeting the cancer initiating cell: the ultimate target for cancer therapy. 53
Terminal deoxynucleotidyl transferase-positive B cell precursors in fetal lymph nodes and extrahemopoietic tissues. 52
Philadelphia-positive chronic myelogenous leukemia with typical bcr/abl molecular features and atypical, prolonged survival. 52
Phorbol ester-induced PKC{epsilon} down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. 51
Terminal deoxynucleotidyl transferase (TdT) in human foetuses. An immunofluorescent and biochemical study. 51
Medicina molecolare: nuovi strumenti per la conoscenza e la cura delle patologie dell'uomo. 49
Leu-7-positive cells with monocyte phenotype show different ultrastructural features in comparison to Leu-7-positive cells with T-cell phenotype. 49
Selective Expression and Constitutive Phosphorylation of SHC Proteins in the CD34+ Fraction of Chronic Myelogenous Leukemias. 48
The combination of MEK inhibitors and Arsenic Trioxide triggers in vitro and in vivo synergistic cytotoxicity in multiple myeloma through multiple signaling pathways 48
Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors. 48
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 47
Progression of a myelodysplastic syndrome to pre-B acute lymphoblastic leukaemia with unusual phenotype. 47
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting. 44
A micro-mechanically motivated model for the strength of heat-treated glass 44
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH plus -LEUKEMIA 42
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. 42
Combined treatment with the MEK inhibitor PD0325901 and Arsenic Trioxide has potent antitumor activity in NOD-SCID mice bearing advanced tumors of human multiple myeloma. 41
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy. 41
Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. 39
null 30
Calibration of the Statistical-Interference Factors for the Design of Tempered Structural Glass 28
Totale 4.819
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 0 75 105 12 77 230 28 78
2020/2021499 2 70 37 3 82 17 35 13 111 19 101 9
2021/2022382 5 10 0 14 12 16 63 72 20 34 18 118
2022/20231.178 139 124 94 87 106 123 5 69 379 14 30 8
2023/2024407 33 47 17 8 55 68 24 9 15 23 34 74
2024/2025649 60 92 105 60 212 120 0 0 0 0 0 0
Totale 4.819